Abstract
The aim of the study was to assess chosen factors of genetic
susceptibility to DMT1: DRB1, DQB1, and TNF-
The aim of the study was to assess chosen factors of genetic
susceptibility to DMT1: DRB1, DQB1, and TNF-
M J Redondo and G S Eisenbarth, “Genetic control of autoimmunity in type I diabetes and associated disorders,” Diabetologia, vol. 45, no. 5, pp. 605–622, 2002.
View at: Google ScholarD Devendra, E Liu, and G S Eisenbarth, “Type 1 diabetes: recent developments,” British Medical Journal, vol. 328, no. 7442, pp. 750–754, 2004.
View at: Google ScholarG I Bell, S Horita, J H Karam et al., “A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus,” Diabetes, vol. 33, no. 2, pp. 176–183, 1984.
View at: Google ScholarM P Marron, L J Raffel, H-J Garchon et al., “Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups,” Human Molecular Genetics, vol. 6, no. 8, pp. 1275–1282, 1997.
View at: Google ScholarJ L Davies, Y Kawaguchi, S T Bennett et al., “A genome-wide search for human type 1 diabetes susceptibility genes,” Nature, vol. 371, no. 6493, pp. 130–136, 1994.
View at: Google ScholarL L Field, “Genetic linkage and association studies of type I diabetes: challenges and rewards,” Diabetologia, vol. 45, no. 1, pp. 21–35, 2002.
View at: Google ScholarJ Nerup, P Platz, O O Andersen et al., “HL-A antigens and diabetes mellitus,” The Lancet, vol. 304, no. 7885, pp. 864–866, 1974.
View at: Google ScholarK S Rønningen, N Keiding, and A Green, “Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes,” Diabetologia, vol. 44, no. suppl 3, pp. B51–B59, 2001, on behalf of Genomic Marker Contributors and the EUORODIAB ACE Study Group.
View at: Google ScholarA G Wilson, J A Symons, T L Mcdowell, H O Mcdevitt, and G W Duff, “Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3195–3199, 1997.
View at: Google ScholarK Hamaguchi, A Kimura, N Seki et al., “Analysis of tumor necrosis factor- promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese,” Tissue Antigens, vol. 55, no. 1, pp. 10–16, 2000.
View at: Google ScholarA Rabinovitch, “Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation?” Diabetes, vol. 43, no. 5, pp. 613–621, 1994.
View at: Google ScholarA Rabinovitch and W L Suarez-Pinzon, “Cytokines and their roles in pancreatic islet -cell destruction and insulin-dependent diabetes mellitus,” Biochemical Pharmacology, vol. 55, no. 8, pp. 1139–1149, 1998.
View at: Google ScholarD L Vaux and R A Flavell, “Apoptosis genes and autoimmunity,” Current Opinion in Immunology, vol. 12, no. 6, pp. 719–724, 2000.
View at: Google ScholarM J Hussain, M Peakman, H Gallati et al., “Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM,” Diabetologia, vol. 39, no. 1, pp. 60–69, 1996.
View at: Google ScholarK M Kroeger, K S Carville, L J Abraham et al., “The -308 tumor necrosis factor- promoter polymorphism effects transcription,” Molecular Immunology, vol. 34, no. 5, pp. 391–399, 1997.
View at: Google ScholarA S Low, I Azmy, N Sharaf, C Cannings, and A G Wilson, “Association between two tumour necrosis factor intronic polymorphisms and HLA alleles,” European Journal of Immunogenetics, vol. 29, no. 1, pp. 31–34, 2002.
View at: Google ScholarA M Uglialoro, D Turbay, P A Pesavento et al., “Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor- gene promoter,” Tissue Antigens, vol. 52, no. 4, pp. 359–367, 1998.
View at: Google ScholarH Obayashi, N Nakamura, M Fukui et al., “Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus,” Human Immunology, vol. 60, no. 10, pp. 974–978, 1999.
View at: Google ScholarM Matsushita, N Tsuchiya, T Nakayama et al., “Allele typing of human TNFA -flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese,” Tissue Antigens, vol. 54, no. 5, pp. 478–484, 1999.
View at: Google ScholarD S Monos, M Kamoun, I A Udalova et al., “Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus: linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes,” Human Immunology, vol. 44, no. 2, pp. 70–79, 1995.
View at: Google ScholarC E Whichelow, G A Hitman, I Raafat, G F Bottazzo, and J A Sachs, “The effect of B gene polymorphism on TNF- and - secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls,” European Journal of Immunogenetics, vol. 23, no. 6, pp. 425–435, 1996.
View at: Google ScholarA Cox, A M Gonzalez, A G Wilson et al., “Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM,” Diabetologia, vol. 37, no. 5, pp. 500–503, 1994.
View at: Google ScholarF Pociot, A G Wilson, J Nerup, and G W Duff, “No independent association between a tumor necrosis factor- promotor region polymorphism and insulin-dependent diabetes mellitus,” European Journal of Immunology, vol. 23, no. 11, pp. 3050–3053, 1993.
View at: Google ScholarA Shtauvere-Brameus, P Dabadghao, I Rumba, and C B Sanjeevi, “Tumor necrosis factor- allele 2 shows an association with insulin-dependent diabetes mellitus in Latvians,” Annals of the New York Academy of Sciences, vol. 958, pp. 357–361, 2002.
View at: Google ScholarWorld Health Organization, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus,” WHO, 1999.
View at: Google ScholarS A Miller, D D Dykes, and H F Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988.
View at: Google ScholarD Turner, S CD Grant, N Yonan et al., “Cytokine gene polymorphism and heart transplant rejection,” Transplantation, vol. 64, no. 5, pp. 776–779, 1997.
View at: Google ScholarS Schneider, D Roessli, and L Excoffier, “Arlequin ver 2.00: a software for population genetics data analysis,” 2000. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
View at: Google ScholarJ Ilonen and H Rejonen, “Special genetic features of populations in Nordic countries as related to risk of IDDM,” Diabetes in the Young, vol. 29, pp. 10–16, 1993.
View at: Google ScholarM Krokowski, J Bodalski, A Bratek, C Boitard, and S Caillat-Zucman, “HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish population,” Human Immunology, vol. 59, no. 7, pp. 451–455, 1998.
View at: Google ScholarA Kretowski and I Kinalska, “DQA1 and DQB1 HLA genes as a markers of insulin-dependent diabetes mellitus in the Polish population,” Polskie Archiwum Medycyny Wewnetrznej, vol. 101, no. 3, pp. 205–211, 1999.
View at: Google ScholarG Y Deng, N K Maclaren, H-S Huang, L-P Zhang, and J-X She, “No primary association between the 308 polymorphism in the tumor necrosis factor promoter region and insulin-dependent diabetes mellitus,” Human Immunology, vol. 45, no. 2, pp. 137–142, 1996.
View at: Google ScholarL Bouqbis, O Akhayat, H-J Garchon, F Calafell, and H Izaabel, “TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population,” Tissue Antigens, vol. 61, no. 1, pp. 72–79, 2003.
View at: Google ScholarM J Hussain, J Maher, T Warnock, A Vats, M Peakman, and D Vergani, “Cytokine overproduction in healthy first degree relatives of patients with IDDM,” Diabetologia, vol. 41, no. 3, pp. 343–349, 1998.
View at: Google Scholar